Pfizer Inc. (@pfizer) / X

Pfizer Inc.

11.4K posts

Pfizer Inc.

@pfizer

We’re celebrating over 175 years of daring scientific innovation and we’re not done yet. Protect your health at PfizerForAll.com on.pfizer.com/CGs

New York, NY

Joined July 2009

Pfizer Inc.
@pfizer
Jul 31
Not all migraine attacks are random. Hormonal shifts across the menstrual cycle can trigger longer, more severe attacks. Here’s what the research reveals about menstrual migraine: on.pfizer.com/4pP1u0x #MigraineAwareness #HormoneHealth #WomensHealth
Pfizer Inc.
@pfizer
Jul 22
“My daughter is my driving force. She’s what I’m truly living for.” After a rare cancer diagnosis, Isis Kanevsky shares the lessons that ground her as she navigates treatment and survivorship. on.pfizer.com/4wSJVip #CancerSurvivorship #CancerAwareness #RareDisease
00:00
Pfizer Inc.
@pfizer
Jun 30
GLP-1. GIP. Amylin. NuSH. What sounds like “alphabet soup” is actually reshaping how researchers understand obesity. New science is revealing how hormones, brain signaling, metabolism, and the gut-brain axis influence weight regulation — and is driving updated approaches to
Pfizer Inc.
@pfizer
Jun 26
For years, Dan Morgan has helped doctors understand the role certain medications can play in cancer care. At age 46, he became a patient. Because he was proactive about prostate cancer screening, doctors caught it early. Now, Dan’s sharing his story. on.pfizer.com/4evVVQH
Pfizer Inc.
@pfizer
Jun 25
The first participants have been dosed in VESPER-6 and SOLIS-1, part of 20+ study starts planned across Pfizer's obesity pipeline in 2026. Learn more about our pipeline: pfizer.com/pipeline
Albert Bourla
@AlbertBourla
Jun 25
We dosed the first participants in VESPER-6, the latest Phase 3 trial of our lead investigational medicine in obesity and started a Phase 2b study testing it in combination with an investigational amylin analog.